The evolution of cell and gene therapy is reshaping drug discovery, providing new hope for rare diseases and cancer through innovative gene editing approaches.

More than 2 years after the child was born, no identifiable features of SMA have been observed, reported Richard Finkel, MD, of St. Jude Children's Research Hospital in Memphis, Tennessee, and ...

The industry is on a strong growth trajectory, with experts predicting notable achievements over the next decade. Forecasts ...

Graphic processing units (GPUs) and artificial intelligence (AI) are among the most searched terms online these days, making ...

The largest gathering of healthcare technology professionals worldwide, HIMSS brings together more than 30,000 attendees to discuss global health topics shaping the next generation of healthcare. John ...

Electromagnetic devices are integral to various sectors, including energy, transportation, communication, and healthcare, impacting everything from power ...

The Dr. Levi Watkins Jr. Medical Accelerated Pathway Program will offer a seven-year medical school option for Tennessee ...

Rezolute , Inc. (NASDAQ:RZLT), a clinical-stage biopharmaceutical company, is making significant strides in the development of its lead drug candidate, ersodetug, for the treatment of congenital ...

Potential delays in clinical trials may result in extended timelines for new drug approvals, and a sudden reduction in ...

Reconstructive surgery, essential for restoring function and appearance after trauma or disease, has undergone significant transformation due to ...